Constares
  • Deutsch Deutsch
  • Kontakt
  • Impressum
  • Datenschutz
  • Über uns
    • Unsere Werte
    • Unsere Mission
    • Unsere Vision
    • Unser Nutzenversprechen
  • Unser Team
    • Christian Limmer
    • James Caan
    • Annemarie Selbenbacher
    • Gunnar Mayr
    • Max Slevogt
    • Nathalie Veh
    • Rebecca Schön
    • Tanja Capljak
    • Ewelina Szymanska
    • Tom Schwarzbach
    • Danijela Malinovic
    • Monika Schäffer
  • Branchen
    • Pharma
    • Biotechnologie
    • Medizintechnik
    • Diagnostik
    • Contract Research Organizations
  • Fachbereiche
    • Klinische Forschung
    • Drug Safety
    • Marketing & Sales
    • Medical Affairs
    • Discovery, Präklinische Forschung & Labor
    • Market Access
    • Regulatory Affairs
    • Quality Assurance
    • Human Resources
    • Finance
    • General Management
  • Services
    • Resourcing
    • Recruiter on demand
    • Staffing
  • Karriereportal
    • Jobangebote
    • Karriereseite
  • Referenzen
  • Brancheninfos
    • IVD (In-vitro-Diagnostik) Unternehmen Liste
    • Clinical Research Organisations Liste
    • Contract Research Organisations Liste
    • Medical & Regulatory Affairs - Consulting Services Liste
  • News
  • EirGenix announces collaboration with Constares

EirGenix announces collaboration with Constares

09. Dezember 2021 · Constares · Annemarie Selbenbacher · Unternehmens News · Aktuelle Infos aus der Healthcare-Industrie · Constares aktuell

 

EirGenix announces collaboration with Constares

Munich, December 9, 2021 - Today EirGenix Europe GmbH and Constares GmbH announced their collaboration to fulfill Eirgenix ambitious growth plans. EirGenix is a successful biotechnology company from Taiwan, which has become the leading biopharmaceutical company in Taiwan in recent years - both as a manufacturer of complex biopharmaceuticals and as a product development company. Since 2016, EirGenix has had its European headquarters in Munich, from where all of the company's global clinical trials are managed. Due to the further internationalization strategy and the associated strong growth, several new positions will also be filled in Europe, for which the services of Constares as a specialized recruitment consultancy for life science positions will be used in the future. In particular, the area of clinical development is expected to grow dynamically in the coming months and years.

About EirGenix:

EirGenix Inc. is a nearly fully integrated biopharmaceutical company operating successfully internationally in two business segments - contract manufacturing of complex biopharmaceutical drugs and development of biosimilars. The company operates from its headquarters in Taiwan (with two manufacturing sites, Taipei, Zhubei) and from Munich, Germany, its European office.

EirGenix is pursuing a steady and sustainable growth strategy in Asia, Europe and the U.S., with the goal of becoming one of the leading biosimilar companies in the world, establishing one of the largest and most effective production sites in Asia, and in doing so, opening up innovative biomedical business areas (e.g. vaccine production and vector development) through its own growth and selective acquisitions.

As a result of its long-term growth, EirGenix is looking for qualified personnel especially in Taiwan for the area of biopharmaceutical drug manufacturing and in Germany for the area of clinical development and regulatory affairs.

About Constares:

Constares is a recruitment consultancy specializing in the life science industry. The company's expertise is based on its many years of experience in filling specialist and management positions in all areas regarding the development and commercialization of active ingredients or medical products. As a medium-sized and owner-managed company, Constares offers individual solutions for its clients, which can be adapted to any respective problem.

With this clear focus, a team of experienced and highly specialized consultants is active in the areas of Clinical Research and Development, Medical Affairs, Regulatory Affairs, Drug Safety, Quality Assurance, Marketing, Sales, Human Resources, Accounting & Controlling and General Management. 

 

Contact Constares GmbH:

Anne Selbenbacher
Partner

Constares GmbH
Elsenheimerstrasse 63, 80687 Munich, Germany
Phone: 0049 89 1250 398 33
annemarie.selbenbacher@constares.com

 

Unternehmens News · Aktuelle Infos aus der Healthcare-Industrie · Constares aktuell
Arzneimittel · Constares Unternehmensnachrichten

Kategorien

  • Aktuelle Infos aus der Healthcare-Industrie (4)
  • Constares aktuell (7)
  • Human Resources Themen (3)
  • Interessant zu wissen (4)
  • Recruiting (1)
  • Referenzen (3)
  • Referenzen von Experts - Mitarbeitern (1)
  • Referenzen von Kandidaten (1)
  • Referenzen von Kunden (1)
  • Rund um die Karriere (7)
  • Unternehmens News (3)

Letzte Blogbeiträge

24. Mai 2022

Meine Erfahrung bei Constares

23. April 2022

Tanja Capljak übernimmt den Bereich Medical Affairs bei Constares

21. März 2022

James Caan joins Constares as Non Executive Director

01. Januar 2022

Max is a very professional and customer focused recruiter

01. Januar 2022

Danke!!

Schlagworte

Market Access Benefits Marketing & Sales Bewerbungsgespräch Arzneimittel Künstliche Intelligenz Constares Unternehmensnachrichten Constares Consultants Arbeitnehmerüberlassung Jobs Life Science Pandemie Experience Medical Affairs & Medical Science Liasion Management Besonderes Recruitingkanäle Recruiting Jobs Constares Mitarbeiter

Archiv

  • 2022
    • Mai (1)
    • April (1)
    • März (1)
  • 2021
    • Dezember (4)
    • Januar (1)
  • 2020
    • Dezember (1)
    • November (1)
    • Oktober (1)
    • September (1)
    • August (1)
    • Juli (1)
    • Juni (1)
    • Mai (2)
    • April (1)
    • März (1)
    • Februar (1)
    • Januar (1)
  • 2019
    • Dezember (1)
    • November (1)
    • Oktober (1)
    • September (1)
Constares
  • Sitemap
  • Impressum
  • Datenschutz
  • Kontakt

Constares GmbH
Hansastraße 10
80686 München

Tel.: 089-125039830
Fax: 089-125039839
Email: info@constares.com

© Constares GmbH 2023